Eeyarestatin I is a novel and potent ERAD (endoplasmic reticulum-associated protein degradation) inhibitor and protein translocation inhibitor with anticancer activity. Acting by inhibiting membrane-bound p97 to disrupt ER homeostasis and to induce tumor cell death.